Student award winner in the undergraduate category for the society of biomaterials 9th World Biomaterials Congress, Chengdu, China, June 1–5, 2012

Journal of Biomedical Materials Research - Part A - Tập 100A Số 6 - Trang 1375-1386 - 2012
Anna K. Blakney1, Mark D. Swartzlander2, Stephanie J. Bryant2
1Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado, USA
2Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado

Tóm tắt

Abstract

Poly(ethylene glycol) (PEG) hydrogels, modified with RGD, are promising platforms for cell encapsulation and tissue engineering. While these hydrogels offer tunable mechanical properties, the extent of the host response may limit their in vivo applicability. The overall objective was to characterize the effects of hydrogel stiffness on the in vitro macrophage response and in vivo host response. We hypothesized that stiffer substrates induce better attachment, adhesion, and increased cell spreading, which elevates the macrophage classically activated phenotype and leads to a more severe foreign body reaction (FBR). PEG‐RGD hydrogels were fabricated with compressive moduli of 130, 240, and 840 kPa, and the same RGD concentration. Hydrogel stiffness did not impact macrophage attachment, but elicited differences in cell morphology. Cells retained a round morphology on 130 kPa substrates, with localized and dense F‐actin and localized αV integrin stainings. Contrarily, cells on stiffer substrates were more spread, with filopodia protruding from the cell, a more defined F‐actin, and greater αV integrin staining. When stimulated with lipopolysaccharide, macrophages had a classical activation phenotype, with increased expression of TNF‐α, IL‐1β, and IL‐6, however the degree of activation was significantly reduced with the softest hydrogels. A FBR ensued in response to all hydrogels when implanted subcutaneously in mice, but 28 days postimplantation the layer of macrophages at the implant surface was significantly lower in the softest hydrogels. In conclusion, hydrogels with lower stiffness led to reduced macrophage activation and a less severe and more typical FBR, and therefore are more suited for in vivo tissue engineering applications. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.

Từ khóa


Tài liệu tham khảo

10.1002/bit.22361

10.1002/adma.200501612

10.1089/ten.tea.2008.0196

10.1016/j.biomaterials.2005.11.007

10.1002/jbm.a.32014

10.1016/j.jbiomech.2008.02.034

10.1016/j.biomaterials.2010.10.017

10.1089/ten.2006.12.1663

10.1016/j.biomaterials.2005.03.018

10.1016/j.smim.2007.11.004

10.1146/annurev.bioeng.6.040803.140027

Anderson JM, 1983, Biocompatibility and the inflammatory response, Abstr Pap Am Chem Soc, 185, 99‐POLY

10.1016/0142-9612(84)90060-7

10.1146/annurev.matsci.31.1.81

10.1002/jbm.a.33015

10.1002/jbm.a.32595

10.1016/0021-9797(91)90043-8

10.1002/jbm.a.31863

10.1016/j.biomaterials.2010.01.074

10.1007/s10439-009-9811-1

10.1016/j.cell.2006.06.044

10.1016/j.biomaterials.2006.09.038

10.1016/S0006-3495(00)76279-5

10.1242/jcs.029678

10.1002/bit.22647

Beningo KA, 2002, Flexible polyacrylamide substrata for the analysis of mechanical interactions at cell‐substratum adhesions, Methods Cell‐Matrix Adhes, 69, 325

10.1002/cm.20130

10.1002/jcp.22356

10.1038/nri2448

10.2353/ajpath.2007.061213

10.1074/jbc.274.16.10689

10.1172/JCI30992

10.1136/jcp.44.11.936

10.1038/nnano.2010.246

10.1038/nbt0695-565

10.1002/jbm.a.32980

10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B

Graves KL, 1996, Fibronectin modulates expression of interleukin‐1 beta and its receptor antagonist in human mononuclear cells, Am J Physiol Lung Cell Mol Physiol, 271, L61, 10.1152/ajplung.1996.271.1.L61

10.1097/00000658-199706000-00013

Erickson CAR, 1989, Clinical Immunology

10.1146/annurev.cellbio.12.1.697

10.1002/jbm.a.31161

10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z

10.1016/S0002-9440(10)64882-1

10.1002/jbm.a.32963

10.1002/(SICI)1097-4636(19990905)46:3<324::AID-JBM3>3.0.CO;2-5

10.1089/ten.2006.12.1955

10.1163/156856206777346340

10.2353/ajpath.2009.080962

10.1016/j.actbio.2010.07.033

10.1002/jbm.a.32893

10.1002/jbm.a.32806

10.1002/jbm.a.32609

10.1016/j.biomaterials.2007.04.035

10.1152/ajpcell.00269.2001

10.1016/j.bpj.2008.10.072

10.1038/nature10316

10.3109/15419069809004479

10.1016/S0142-1123(00)00052-9

10.1002/jbm.1217

10.1016/S0142-9612(02)00176-X

10.1021/bm050663e

10.1016/j.actbio.2010.08.021

10.1002/jbm.a.32787